Enrique Miranda Rota
About Enrique Miranda Rota
Enrique Miranda Rota is a Principal Scientist at Onena Medicines, with over a decade of academic and professional experience at University College London. His research focuses on the discovery of novel antibodies for clinical applications, supported by a strong background in oncology and extensive experience in proteomics.
Work at Onena Medicines
Enrique Miranda Rota has been serving as Principal Scientist at Onena Medicines since 2021. In this role, he focuses on the discovery of novel antibodies for clinical applications. His work is informed by his extensive background in oncology and cancer biology, allowing him to contribute significantly to the company's research initiatives.
Education and Expertise
Enrique Miranda Rota possesses a diverse educational background, holding degrees in biochemistry and molecular biology. He earned a Bachelor of Science (BSc) in Molecular Biology from Universidad de Navarra from 1999 to 2003, followed by a Bachelor of Science (BSc) in Biochemistry from the same institution from 2003 to 2004. He further advanced his studies by obtaining a PhD in Oncology and Cancer Biology from Barts and The London, Queen Mary University, from 2005 to 2009.
Background
Enrique Miranda Rota has a long-standing academic and professional connection with University College London (UCL), spanning over a decade. He worked as a Research Associate at UCL from 2009 to 2018 and later as a Senior Research Fellow from 2018 to 2021. Additionally, he managed the non-mass spec proteomics facility at the UCL Cancer Institute from 2019 to 2021, which provided him with extensive experience in proteomics.
Professional Experience
Prior to his current role, Enrique Miranda Rota held various positions that contributed to his expertise. He worked as a Microbiologist at Abbott for eight months in 2005 and interned in the Department of Microbiology at Universidad de Navarra from 2001 to 2003. His diverse roles have equipped him with a multidisciplinary approach to scientific research.
Research Focus
Enrique Miranda Rota's research primarily focuses on the discovery of novel antibodies for clinical applications. His strong background in oncology and cancer biology informs his research interests, allowing him to explore innovative solutions in the field. His experience in proteomics further enhances his ability to contribute to advancements in cancer research.